Skip to main content
SpringerLink
Log in

Gastrointestinal Motility Problems in Patients with Parkinson’s Disease

Epidemiology Pathophysiology and Guidelines for Management

  • Disease Management
  • Published:
CNS Drugs Aims and scope Submit manuscript

Abstract

Gastrointestinal dysfunction is a frequent feature of Parkinson’s disease and may be characterised by disordered salivation, dysphagia, gastroparesis, constipation and defecatory dysfunction.

Excess saliva is noted by at least 70% of patients with Parkinson’s disease and is caused by decreased swallowing frequency rather than overproduction of saliva. Treatment is largely nonpharmacological, although more effective management of dysphagia may also reduce saliva accumulation. Anticholinergic drugs are best avoided

Dysphagia develops in 50% or more of individuals with Parkinson’s disease and may be due to oral, pharyngeal or oesophageal factors. Behavioural techniques taught by a speech/swallowing therapist may be useful, but optimum employment of dopaminergic medications may also provide significant improvement in 30 to 40% of patients. Surgical approaches, such as cricopharyngeal myotomy, may be appropriate in selected individuals

Impaired gastric emptying may occur in Parkinson’s disease and interfere with levodopa absorption in addition to producing bloating and other symptoms. Prokinetic agents, such as cisapride and domperidone, have been successfully utilised for this problem

Bowel dysfunction in Parkinson’s disease has been separated into constipation, due to slowed colon transit, and defecatory dysfunction, due to discoordinated anorectal muscular function, but the two conditions often coexist. Fibre, fluid and prokinetic agents may improve constipation; unproven modalities, such as apomorphine and botulinum toxin injections, may hold the best promise for ameliorating defecatory dysfunction

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkinson J. An essay on the shaking palsy. London: Whittingham and Rowland, 1817

    Google Scholar 

  2. Romberg MH. Nervous diseases of man. London: Sydenham Society, 1853

    Google Scholar 

  3. Charcot JM. Lectures on the diseases of the nervous system. Vol. 1. London: New Sydenham Society, 1877

    Google Scholar 

  4. Hammond WA. A treatise on diseases of the nervous system. New York: Appleton & Co., 1871

    Google Scholar 

  5. Gowers WR. Diseases of the nervous system. Philadelphia (PA): PBlakiston& Co., 1888

    Google Scholar 

  6. Eadie MJ, Tyrer JH. Alimentary disorder in parkinsonism. Aust Ann Med 1965; 14: 13–22

    PubMed  CAS  Google Scholar 

  7. Edwards LL, Pfeiffer RF, Quigley EMM, et al. Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 1991; 6: 151–6

    Article  PubMed  CAS  Google Scholar 

  8. Edwards LL, Quigley EMM, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease: frequency and pathophysiology. Neurology 1992; 42: 726–32

    Article  PubMed  CAS  Google Scholar 

  9. Edwards L, Quigley EMM, Hofman R, et al. Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study. Mov Disord 1993; 8: 83–6

    Article  PubMed  CAS  Google Scholar 

  10. Edwards LL, Quigley EMM, Harned RK, et al. Characterization of swallowing and defecation in Parkinson’s disease. Am J Gastroenterol 1994; 89: 15–25

    PubMed  CAS  Google Scholar 

  11. Quigley EMM. Gastrointestinal dysfunction in Parkinson’s disease. Semin Neurol 1996; 16: 245–50

    Article  PubMed  CAS  Google Scholar 

  12. Quigley EMM. Epidemiology and pathophysiology of gastrointestinal manifestations in Parkinson’s disease. In: Corazziari E, editor. Neurogastroenterology. Berlin: deGruyter, 1996: 167–78

    Google Scholar 

  13. Bateson MC, Gibberd FB, Wilson RSE. Salivary symptoms in Parkinson’s disease. Arch Neurol 1973; 29: 274–5

    Article  PubMed  CAS  Google Scholar 

  14. Eadie MJ. Gastric secretion in parkinsonism. Aust Ann Med 1963; 12: 346–50

    PubMed  CAS  Google Scholar 

  15. Korczyn AD. Autonomic nervous system dysfunction in Parkinson’s disease. In: Calne DB, Comi G, Crippa D, et al editors. Parkinsonism and aging. New York (NY): Raven Press, 1989: 211–9

    Google Scholar 

  16. Marsden CD. Gastrointestinal manifestations of movement disorders. In: Corazziari E, editor. Neurogastroenterology. Berlin: deGruyter, 1996: 161–5

  17. Korczyn AD. Autonomic nervous system disturbances in Parkinson’s disease. In: Streifler MB, Korczyn AD, Melamed E, et al., editors. Parkinson’s disease: anatomy, pathology and therapy (Advances in neurology, vol. 53). New York (NY): Raven Press, 1990: 463–8

    Google Scholar 

  18. Leopold NA, Kagel MC. Prepharyngeal dysphagia in Parkinson’s disease. Dysphagia 1996; 11: 14–22

    Article  PubMed  CAS  Google Scholar 

  19. Logemann JA, Blonsky ER, Boshes B. Editorial: dysphagia in parkinsonism. JAMA 1975; 231(1): 69–70

    Article  PubMed  CAS  Google Scholar 

  20. Bushman M, Dobmeyer SM, Leeker L, et al. Swallowing abnormalities and their response to treatment in Parkinson’s disease. Neurology 1989; 39: 1309–14

    Article  Google Scholar 

  21. Robbins JA, Logemann JA, Kirshner HS. Swallowing and speech production in Parkinson’s disease. Ann Neurol 1986; 19: 283–7

    Article  PubMed  CAS  Google Scholar 

  22. Ali GN, Wallace KL, Schwartz R, et al. Mechanisms of oralpharyngeal dysphagia in patients with Parkinson’s disease. Gastroenterology 1996; 110: 383–92

    Article  PubMed  CAS  Google Scholar 

  23. Johnston BT, Li Q, Castell JA, et al. Swallowing and esophageal dysfunction in Parkinson’s disease. Am J Gastroenterol 1995; 90: 1741–6

    PubMed  CAS  Google Scholar 

  24. Stroudley J, Walsh M. Radiological assessment of dysphagia in Parkinson’s disease. Br J Radiol 1991; 64: 890–3

    Article  PubMed  CAS  Google Scholar 

  25. Mari F, Matei M, Bartolini M, et al. Poor predictive value of clinical measures of dysphagia versus aspiration risk in parkinsonian patients [abstract]. Mov Disord 1997; 12( Suppl. 1): 135

    Google Scholar 

  26. Logemann J, Blonsky ER, Boshes B. Lingual control in Parkinson’s disease. Trans Am Neurol Assoc 1973; 98: 276–8

    PubMed  CAS  Google Scholar 

  27. Blonsky ER, Logemann JA, Boshes B, et al. Comparison of speech and swallowing function in patients with tremor disorders and in normal geriatric patients: a cinefluorographic study. J Gerontol 1975; 30: 299–303

    PubMed  CAS  Google Scholar 

  28. Silbiger ML, Pikielny R, Donner MW. Neuromuscular disorders affecting the pharynx. Cineradiographic analysis. Invest Radiol 1967; 2: 442–8

    CAS  Google Scholar 

  29. Byrne KG, Pfeiffer RF, Quigley EMM. Gastrointestinal dysfunction in Parkinson’s disease: a report of clinical experience at a single center. J Clin Gastroenterol 1994; 19: 11–6

    Article  PubMed  CAS  Google Scholar 

  30. Groher ME. Dysphagic patients with progressive neurologic disease. Semin Neurol 1996; 16: 355–63

    Article  PubMed  CAS  Google Scholar 

  31. Logeman JA. Screening, diagnosis and management of neurogenic dysphagia. Semin Neurol 1996; 16: 319–27

    Article  Google Scholar 

  32. Penner A, Druckerman LJ. Segmental spasms of the esophagus and their relation to parkinsonism. Am J Dig Dis 1942; 9: 282–6

    Article  Google Scholar 

  33. Bramble MG, Cunliffe J, Dellipani AW. Evidence for a change in neurotransmitter affecting oesophageal motility in Parkinson’s disease. J Neurol Neurosurg Psychiat 1978; 41: 709–12

    Article  PubMed  CAS  Google Scholar 

  34. Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism — chronic treatment with L-dopa. N Engl J Med 1969; 280: 337–45

    Article  PubMed  CAS  Google Scholar 

  35. Calne DB, Shaw DG, Spiers ASD, et al. Swallowing in parkinsonism. Br J Radiol 1970; 43: 456–7

    Article  PubMed  CAS  Google Scholar 

  36. Paulson GR, Tafrate RH. Some minor aspects of parkinsonism, especially pulmonary function. Neurology 1970; 20: 14–7

    Article  CAS  Google Scholar 

  37. Nowack WJ, Hatelid JM, Sohn RS. Dysphagia in parkinsonism [letter]. Arch Neurol 1977; 34; 320

    Article  PubMed  CAS  Google Scholar 

  38. Lieberman AN, Horowitz L, Redmond P, et al. Dysphagia in Parkinson’s disease. Am J Gastroenterol 1980; 74: 157–60

    PubMed  CAS  Google Scholar 

  39. Kempster PA, Lees AJ, Crichton P, et al. Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson’s disease and its treatment with apomorphine. Mov Disord 1989; 4: 47–52

    Article  PubMed  CAS  Google Scholar 

  40. Tison F, Wiart L, Guatterie M, et al. Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson’s disease. Mov Disord 1996; 11: 729–32

    Article  PubMed  CAS  Google Scholar 

  41. Qualman SJ, Haupt HM, Yang P, et al. Oesophageal Lewy bodies associated with ganglion cell loss in achalasia. Gastroenterology 1984; 87: 848–56

    PubMed  CAS  Google Scholar 

  42. Born LJ, Harned RH, Rikkers LF, et al. Cricopharyngeal dysfunction in Parkinson’s disease: role in dysphagia and response to myotomy. Mov Disord 1996; 11: 53–8

    Article  PubMed  CAS  Google Scholar 

  43. Palmer ED. Dysphagia in parkinsonism. JAMA 1974; 229(10): 1349

    Article  PubMed  CAS  Google Scholar 

  44. Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol 1996; 16: 203–16

    Article  PubMed  CAS  Google Scholar 

  45. Sulla M, Hardoff R, Giladi N, et al. Gastric emptying time and gastric motility in patients with untreated Parkinson’s disease [abstract]. Mov Disord 1996; 11 Suppl. 1: 167

    Google Scholar 

  46. Djaldetti R, Baron J, Ziv I, et al. Gastric emptying in Parkinson’s disease: patients with and without response fluctuations. Neurology 1996; 46: 1051–4

    Article  PubMed  CAS  Google Scholar 

  47. Wade DN, Mearrick PT, Morris J. Active transport of l-dopa in the intestine. Nature 1973; 242: 463–5

    Article  PubMed  CAS  Google Scholar 

  48. Sasahara K, Nitanai J, Habara T, et al. Dosage from design for improvement of bioavailability of levodopa: absorption and metabolism of levodopa in intestinal segment of dogs. J Pharm Sci 1981; 70: 1157–60

    Article  PubMed  CAS  Google Scholar 

  49. Nutt JG, Fellman JH. Pharmacokinetics of levodopa. Clin Neuropharmacol 1984; 7: 35–50

    Article  PubMed  CAS  Google Scholar 

  50. Evans MA, Broe GA, Triggs EJ, et al. Gastric emptying rate nd the systemic availability of levodopa in the elderly parkinsonian patient. Neurology 1981; 31: 1288–94

    Article  PubMed  CAS  Google Scholar 

  51. Valenzuala JE. Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 1976; 71: 1019–22

    Google Scholar 

  52. Berkowitz DM, McCallum RW. Interaction of levodopa and metoclopramide on gastric emptying. Clin Pharmacol Ther 1980; 27: 414–20

    Article  PubMed  CAS  Google Scholar 

  53. Kurlan R, Rothfield KP, Woodward WR, et al. Erratic gastric emptying of levodopa may cause ‘random’ fluctuations of parkinsonian mobility. Neurology 1988; 38: 419–21

    Article  PubMed  CAS  Google Scholar 

  54. Syed N, Murphy J, Zimmerman Jr T, et al. Ten years’ experience with enteral levodopa infusions for motor fluctuations in Parkinson’s disease. Mov Disord 1998; 13: 336–8

    Article  PubMed  CAS  Google Scholar 

  55. Djaldetti R, Melamed E. Levodopa ethylester: a novel rescue therapy for response fluctuations in Parkinson’s disease. Ann Neurol 1996; 39: 400–4

    Article  PubMed  CAS  Google Scholar 

  56. Vaamonde J, Luquin MR, Obeso J. Subcutaneous lisuride infusion in Parkinson’s disease. Response to chronic administration in 34 patients. Brain 1991; 114: 604–17

    Google Scholar 

  57. Stibe CM, Lees AJ, Kempster PA, et al. Subcutaneous apomorphine in parkinsonian on-off oscillations. Lancet 1988; 1: 403–6

    Article  PubMed  CAS  Google Scholar 

  58. Kleedorfer B, Turjanski N, Ryan R, et al. Intranasal apomorphine in Parkinson’s disease. Neurology 1991; 41: 761–2

    Article  PubMed  CAS  Google Scholar 

  59. Montrastruc JL, Rascol O, Senard JM, et al. Sublingual apomorphine in Parkinson’s disease: a clinical and pharmacokinetic study. Clin Neuropharmacol 1991; 14: 432–7

    Article  Google Scholar 

  60. van Laar T, Jansen ENH, Neef C, et al. Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson’s disease: a study of five different suppositories. Mov Disord 1995; 10: 433–9

    Article  PubMed  Google Scholar 

  61. Hughes AJ, Bishop S, Kleedorfer B, et al. Subcutaneous apomorphine in Parkinson’s disease: response to chronic administration for up to five years. Mov Disord 1993; 8: 165–70

    Article  PubMed  CAS  Google Scholar 

  62. Mouradian MM, Chase TN. Improved dopaminergic therapy of Parkinson’s disease. In: Marsden CD, Fahn S, editors. Movement Disorders 3. Oxford: Butterworth-Heinemann 1994: 180–9

    Google Scholar 

  63. Calabrese VP, Vaughan J, Lucas J, et al. N-0923, a transdermal amino tetralin D2 dopamine agonist in the treatment of Parkinson’s disease [abstract]. Neurology 1997; 48 Suppl. 2: A270

    Google Scholar 

  64. Wiseman LR, Faulds D. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47: 116–52

    CAS  Google Scholar 

  65. Djaldetti R, Koren M, Ziv I, et al. Effect of cisapride on response fluctuations in Parkinson’s disease. Mov Disord 1995; 10: 81–4

    Article  PubMed  CAS  Google Scholar 

  66. Soykan I, Sarosiek I, Shifflett J, et al. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastricemptying in patients with Parkinson’s disease. Mov Disord 1997; 12: 952–7

    Article  PubMed  CAS  Google Scholar 

  67. Farrugia G, Camilleri M, Whitehead WE. Therapeutic strategies for motility disorders. Medications, nutrition, biofeedback, and hypnotherapy. Gastroenterol Clin 1996; 25: 225–46

    CAS  Google Scholar 

  68. Ashraf W, Park F, Lof J, et al. An examination of reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996; 91: 26–32

    PubMed  CAS  Google Scholar 

  69. Schwab RS, England AC. Parkinson’s disease. J Chronic Dis 1958; 8: 488–509

    Article  PubMed  CAS  Google Scholar 

  70. Pallis CA. Parkinsonism: natural history and clinical features. Br Med J 1971; 3: 683–90

    Article  PubMed  CAS  Google Scholar 

  71. Jost WH, Schimrigk K. Constipation in Parkinson’s disease. Klin Wochenschr 1991; 69: 906–9

    Article  PubMed  CAS  Google Scholar 

  72. Ashraf W, Pfeiffer RF, Park F, et al. Constipation in Parkinson’s disease: objective assessment and response to psyllium. Mov Disord 1997; 12: 946–51

    Article  PubMed  CAS  Google Scholar 

  73. Kupsky WJ, Grimes MM, Sweeting J, et al. Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 1987; 37: 1253–5

    Article  PubMed  CAS  Google Scholar 

  74. Wakabayashi K, Takahashi K, Ohama E, et al. Parkinson ’s disease: an immunohistochemical study of Lewy-body containing neurons in the enteric nervous system. Acta Neuropathol 1990; 79: 581–3

    Article  PubMed  CAS  Google Scholar 

  75. Wakabayashi K, Takahashi H, Ohama E, et al. Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease. In: Narabayashi H, Nagatsu T, Yanagisawa N, et al., editors. Parkinson’s disease. From basic research to treatment (Advances in neurology vol. 60). New York (NY): Raven Press, 1993: 609–12

    Google Scholar 

  76. Singaram C, Ashraf W, Gaumnitz EA, et al. Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation. Lancet 1995; 346: 861–4

    Article  PubMed  CAS  Google Scholar 

  77. Lewitan A, Nathanson L, Slade WR Jr. Megacolon and dilatation of the small bowel in parkinsonism. Gastroenterology 1952; 17: 367–74

    Google Scholar 

  78. Caplan LH, Jacobson HG, Rubinstein BM, et al. Megacolon and volvulus in Parkinson’s disease. Radiology 1965; 85: 73–8

    PubMed  CAS  Google Scholar 

  79. Rosenthal MJ, Marshall CE. Sigmoid volvulus in association with parkinsonism. Report of four cases. J Am Geriatr Soc 1987; 35: 683–4

    CAS  Google Scholar 

  80. Bak MP, Boley SJ. Sigmoid volvulus in elderly patients. Am J Surg 1986; 151: 71–5

    Article  PubMed  CAS  Google Scholar 

  81. Corazziari E, Badiali D. Management of lower gastrointestinal tract dysfunction. Semin Neurol 1996; 16: 289–96

    Article  PubMed  CAS  Google Scholar 

  82. Astarloa R, Mena MA, Sanchez V, et al. Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson’s disease. Clin Neuropharmacol 1992; 15: 375–80

    Article  PubMed  CAS  Google Scholar 

  83. Corazziari E, Badiali D, Habib FI, et al. Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci 1996; 41: 1636–42

    Article  PubMed  CAS  Google Scholar 

  84. Jost WH, Schimrigk K. Cisapride treatment of constipation in Parkinson’s disease. Mov Disord 1993; 8: 339–43

    Article  PubMed  CAS  Google Scholar 

  85. Jost WH, Schimrigk K. Long-term results with cisapride in Parkinson’s disease. Mov Disord 1997; 12: 423–5

    Article  PubMed  CAS  Google Scholar 

  86. Sempere AP, Duarte J, Cabezas C, et al. Aggravation of parkinsonian tremor by cisapride. Clin Neuropharmacol 1995; 18: 76–8

    Article  PubMed  CAS  Google Scholar 

  87. Sadjadpour K. Pyridostigmine bromide and constipation in Parkinson’s disease [letter]. JAMA 1983; 249: 1148

    Article  PubMed  CAS  Google Scholar 

  88. Madoff RD, Williams JG, Caushaj PF. Fecal incontinence. N Engl J Med 1992; 326: 1002–7

    Article  PubMed  CAS  Google Scholar 

  89. Parks AG. Anorectal incontinence. Proc R Soc Med 1975; 68: 681–90

    PubMed  CAS  Google Scholar 

  90. Mathers SE, Kempster PA, Swash M, et al. Constipation and paradoxical puborectalis contraction in anismus and Parkinson’s disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatr 1988; 51: 1503–7

    Article  PubMed  CAS  Google Scholar 

  91. Mathers SE, Kempster PA, Law PJ, et al. Anal sphincter dysfunction in Parkinson’s disease. Arch Neurol 1989; 46: 1061–4

    Article  PubMed  CAS  Google Scholar 

  92. Ashraf W, Wszolek ZK, Pfeiffer RF, et al. Anorectal function in fluctuating (on-off) Parkinson’s disease: evaluation by combined anorectal manometry and electromyography. Mov Disord 1995; 10: 650–7

    Article  PubMed  CAS  Google Scholar 

  93. Stocchi F, Vacca L, D’Alba L, et al. Anorectal motor function in patients with Parkinson’s disease [abstract]. Mov Disord 1996; 11 Suppl. 1: 182

    Google Scholar 

  94. Jost WH. Electromyogram of the external anal sphincter in idiopathic Parkinson’s syndrome [abstract]. Mov Disord 1996; 11 Suppl. 1: 192

    Google Scholar 

  95. Ashraf W, Pfeiffer RF, Quigley EMM. Anorectal manometry in the assessment of anorectal function in Parkinson’s disease: a comparison with chronic idiopathic constipation. Mov Disord 1994; 9: 655–63

    Article  PubMed  CAS  Google Scholar 

  96. Edwards LL, Quigley EMM, Harned RK, et al. Defecatory function in Parkinson’s disease: response to apomorphine. Ann Neurol 1993; 33: 490–3

    Article  PubMed  CAS  Google Scholar 

  97. Albanese A, Maria G, Bentivoglio A. Severe constipation in Parkinson’s disease relieved by botulinum toxin. Mov Disord 1997; 12: 764–6

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurodegenerative Diseases, Department of Neurology, University of Tennessee, 855 Monroe Avenue, Room 415, Memphis, Tennessee, USA

    Ronald F. Pfeiffer

  2. Section of Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, Nebraska, USA

    Eamonn M. M. Quigley

Authors
  1. Ronald F. Pfeiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eamonn M. M. Quigley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ronald F. Pfeiffer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfeiffer, R.F., Quigley, E.M.M. Gastrointestinal Motility Problems in Patients with Parkinson’s Disease. Mol Diag Ther 11, 435–448 (1999). https://doi.org/10.2165/00023210-199911060-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00023210-199911060-00003

Keywords

Search

Navigation